Montreal, QC March 31, 2008 -- TrialStat Corporation, the industry's first clinical data solutions on demand company, today continued to shape discussion around adaptive clinical trials by participating in the E-Clinical Trials conference in Montreal. John Simpson, Director, Product Strategy will speak on Adaptive Clinical Trials - How Should They be Managed Using EDC on Tuesday April 1 at the InterContinental Hotel. Mr. Simpson's presentation examines a clinical technology ecosystem managed by EDC. The integrated approach hinges on managing in real-time disparate technologies and sources of data for optimal flexibility. The net effect is increased patient safety, decreased trial development timelines and decreased clinical trial costs. The two-day conference looks at how new technologies are becoming integrated into clinical trials and processes.

As a SaaS or on demand EDC solution, TrialStat's ClinicalAnalytics 4.0™ (CA 4.0) enables organizations to deploy their studies twice as fast as the industry average, which reduces the time and cost associated with drug development. CA 4.0 provides contract research organizations and biopharma organizations with an innovative EDC platform that enables the rapid deployment and management of adaptive clinical trial designs.

Details of the presentation are:

Who: John Simpson, Director Product Strategy

When: April 1 at 2:30pm (EST)

Where: InterContinental Hotel, Montreal, Quebec

What: Adaptive Clinical Trials - How Should They be Managed Using EDC

TrialStat will demonstrate CA 4.0 at BOOTH 1. To request a copy of the presentation, please contact the TrialStat media representative below.

For media inquiries, please contact:
Muay Lim
TrialStat Corporation
613-741-9909 ext 153
mlim(at)trialstat.com
ClinicalAnalytics 4.0 is a register